D. Pfau et al., ABNORMAL DENDRITIC MATURATION OF NEURONS UNDER THE INFLUENCE OF A TILORONE(R) ANALOG (R-10.874), Experimental and toxicologic pathology, 47(5), 1995, pp. 367-374
Tilorone analogue (R 10.874) has a close affinity to the lysosomal com
partment of cells and forms a non degradable carbohydrate-lipid-drug c
omplex accumulated within digesting organelles. Resembling biochemical
and structural changes are seen in hereditary mucopolysaccharidoses a
ccompanied with abnormal dendritogenesis. On the other hand, developme
ntal toxicity (TERRY et al. 1992), antiproliferative effects (ALGARRA
et al. 1993) and interactions with DNA (GELLER et al. 1985) are genera
ted by tilorone. Therefore it should be interesting to know whether th
e amphiphilic cationic compound is able to produce an abnormal den-dri
togenesis as in storage diseases or an impaired arborisation of dendri
tes and what could be the reason for the misdevelopment. We demonstrat
e that there was a fetal retardation in the development of dendritic n
etwork, even under influence of low dosis of the analogue R 10.874. Th
e dendritic dismaturation was concomitant with an increased amount of
fatty acids and a slightly disarranged metabolic pathway of gangliosid
es. The dendritic arborisation closed the gap of retarded development
between intrauterine treated and untreated rats after 7 days of postna
tal drug elimination. We suppose that a fetotoxic effect and not the l
ysosomopathy is responsible for the reduced dendritic network.